Medinotec Valuation

Is MDNC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MDNC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MDNC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MDNC's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MDNC?

Key metric: As MDNC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MDNC. This is calculated by dividing MDNC's market cap by their current revenue.
What is MDNC's PS Ratio?
PS Ratio48.1x
SalesUS$1.22m
Market CapUS$58.67m

Price to Sales Ratio vs Peers

How does MDNC's PS Ratio compare to its peers?

The above table shows the PS ratio for MDNC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.6x
OWLT Owlet
0.7x21.0%US$57.1m
LUCD Lucid Diagnostics
13.2x54.3%US$55.4m
HYPR Hyperfine
5.6x21.0%US$71.2m
MLSS Milestone Scientific
6.8x17.5%US$55.1m
MDNC Medinotec
48.1xn/aUS$58.7m

Price-To-Sales vs Peers: MDNC is expensive based on its Price-To-Sales Ratio (48.1x) compared to the peer average (7.2x).


Price to Sales Ratio vs Industry

How does MDNC's PS Ratio compare vs other companies in the US Medical Equipment Industry?

50 CompaniesPrice / SalesEstimated GrowthMarket Cap
INGN Inogen
0.7x4.2%US$219.37m
ARAY Accuray
0.4x5.5%US$190.07m
NVRO Nevro
0.4x2.5%US$163.38m
KEQU Kewaunee Scientific
0.6xn/aUS$122.83m
MDNC 48.1xIndustry Avg. 3.2xNo. of Companies50PS02.85.68.411.214+
50 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MDNC is expensive based on its Price-To-Sales Ratio (48.1x) compared to the US Medical Equipment industry average (3.2x).


Price to Sales Ratio vs Fair Ratio

What is MDNC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MDNC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio48.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MDNC's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies